| Surgery | Lifetime | 280 | DE 13 | 99.76 |
| Pulmonary and Respiratory Medicine | Lifetime | 421 | DE 18 | 99.45 |
| Urology | Lifetime | 69 | DE 3 | 99.24 |
| Rheumatology | Lifetime | 980 | DE 51 | 94.01 |
| Obstetrics and Gynecology | Lifetime | 928 | DE 19 | 83.45 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 211 | DE 8 | 98.39 |
| Surgery | 2021-2025 | 488 | DE 27 | 96.10 |
| Oncology | 2021-2025 | 904 | DE 44 | 84.09 |
| Urology | 2021-2025 | 151 | DE 6 | 79.54 |
| Urological Disorders and Treatments | Lifetime | 18 | DE 1 | 99.79 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 39 | DE 1 | 99.72 |
| Urinary and Genital Oncology Studies | Lifetime | 26 | DE 1 | 99.73 |
| Ureteral procedures and complications | Lifetime | 48 | DE 2 | 99.07 |
| Cancer Diagnosis and Treatment | Lifetime | 214 | DE 7 | 98.68 |
| Prostate Cancer Treatment and Research | Lifetime | 244 | DE 16 | 99.21 |
| Renal cell carcinoma treatment | Lifetime | 204 | DE 8 | 98.96 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 246 | DE 14 | 98.39 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 567 | DE 27 | 98.75 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 306 | DE 36 | 98.16 |
| Urinary Bladder and Prostate Research | Lifetime | 257 | DE 13 | 98.48 |
| Cancer, Lipids, and Metabolism | Lifetime | 420 | DE 16 | 98.39 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 466 | DE 28 | 98.53 |
| Pelvic floor disorders treatments | Lifetime | 522 | DE 20 | 97.45 |
| Urologic and reproductive health conditions | Lifetime | 387 | DE 23 | 97.64 |
| Urinary Tract Infections Management | Lifetime | 454 | DE 16 | 97.16 |
| Pediatric Urology and Nephrology Studies | Lifetime | 619 | DE 22 | 96.80 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 387 | DE 12 | 93.52 |
| Renal and related cancers | Lifetime | 936 | DE 58 | 96.15 |
| Kidney Stones and Urolithiasis Treatments | Lifetime | 493 | DE 21 | 95.65 |
| Genital Health and Disease | Lifetime | 895 | DE 43 | 93.31 |
| Multiple and Secondary Primary Cancers | Lifetime | 874 | DE 37 | 92.24 |
| Prostate Cancer Treatment and Research | 2021-2025 | 159 | DE 18 | 98.29 |
| Renal cell carcinoma treatment | 2021-2025 | 208 | DE 9 | 96.62 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 230 | DE 11 | 97.15 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 279 | DE 47 | 93.83 |
| Urinary and Genital Oncology Studies | 2021-2025 | 196 | DE 10 | 95.12 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 504 | DE 43 | 94.81 |
| Urological Disorders and Treatments | 2021-2025 | 537 | DE 32 | 88.48 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 842 | DE 35 | 84.98 |
| Urologic and reproductive health conditions | 2021-2025 | 967 | DE 86 | 70.70 |